Revance Therapeutics, Inc.
RVNCDelisted Feb 6, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001479290
Revance Therapeutics, Inc. was delisted on Feb 6, 2025; its insiders filed their last Form 4 on Feb 6, 2025; 174 institutions reported holding it in 13F filings for Q4 2024, worth $249.2M in total; Fairfax Financial was the only superinvestor holding it.
13F holders, Q1 2023
Institutional positions in Revance Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 217
- +26 vs. Q4 2022
- Shares held
- 76.3M
- +2.82M (+3.8%) vs. Q4 2022
- Total value
- $2.46B
- +$1.11B (+81.7%) vs. Q4 2022
- New holders
- 51
- 63 more added
- Sold out
- 25
- 74 more reduced
2 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RVNC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 2 | $425.0K |
| Q4 2024 | 174 | $249.2M |
| Q3 2024 | 201 | $429.9M |
| Q2 2024 | 173 | $209.3M |
| Q1 2024 | 188 | $409.4M |
| Q4 2023 | 193 | $636.4M |
| Q3 2023 | 187 | $893.1M |
| Q2 2023 | 215 | $2.07B |
| Q1 2023 | 217 | $2.46B |
| Q4 2022 | 193 | $1.36B |
| Q3 2022 | 182 | $1.82B |
| Q2 2022 | 161 | $774.3M |
| Q1 2022 | 156 | $1.06B |
| Q4 2021 | 151 | $864.7M |
| Q3 2021 | 159 | $1.53B |
| Q2 2021 | 161 | $1.60B |
| Q1 2021 | 149 | $1.53B |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Revance Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jericho Capital Asset Management L.P. | 1,438,669 | $46.3M | 1.92% | +503,000+53.8% | Added |
| Allspring Global Investments Holdings, LLC | 1,537,250 | $49.5M | 0.08% | +442,726+40.4% | Added |
| Two Sigma Advisers, LP | 1,549,500 | $49.9M | 0.13% | +383,800+32.9% | Added |
| Geode Capital Management, LLC | 1,596,514 | $51.4M | 0.01% | +62,069+4.0% | Added |
| Jennison Associates LLC | 1,633,305 | $52.6M | 0.05% | −392,720−19.4% | Reduced |
| FMR LLC | 1,845,232 | $59.4M | 0.01% | +35,977+2.0% | Added |
| State Street Corp | 1,947,763 | $62.7M | 0.00% | −101,832−5.0% | Reduced |
| Alliancebernstein L.P. | 1,978,557 | $63.7M | 0.03% | +1,894,157+2,244.3% | Added |
| Thrivent Financial for Lutherans | 2,020,981 | $65.1M | 0.16% | +1,946,680+2,620.0% | Added |
| Franklin Resources Inc | 2,274,491 | $73.3M | 0.04% | −110,099−4.6% | Reduced |
| D. E. Shaw & Co., Inc. | 2,291,911 | $73.8M | 0.12% | +952,991+71.2% | Added |
| Polar Capital Holdings Plc | 4,167,842 | $134.2M | 0.98% | −680,791−14.0% | Reduced |
| Vanguard Group Inc | 4,599,745 | $148.2M | 0.00% | +103,429+2.3% | Added |
| JPMorgan Chase & Co | 5,164,157 | $166.3M | 0.02% | +149,735+3.0% | Added |
| Palo Alto Investors LP | 5,270,209 | $169.8M | 14.06% | −13,400−0.3% | Reduced |
| BlackRock Inc. | 6,139,064 | $197.7M | 0.01% | −934,799−13.2% | Reduced |
| Capital World Investors | 10,076,101 | $324.6M | 0.07% | +595,945+6.3% | Added |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −729,097−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −147,500−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −123,821−100.0% | Sold out |
| Moody Aldrich Partners LLC | 0 | $0 | 0.00% | −114,173−100.0% | Sold out |
| Ghisallo Capital Management LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −62,903−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −45,659−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −36,302−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −28,390−100.0% | Sold out |
| Numerai GP LLC | 0 | $0 | 0.00% | −26,444−100.0% | Sold out |
| Banco BTG Pactual S.A. | 0 | $0 | 0.00% | −24,200−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −19,000−100.0% | Sold out |
| Capital Fund Management S.A. | 0 | $0 | 0.00% | −16,900−100.0% | Sold out |
| Glenmede Trust Co NA | 0 | $0 | 0.00% | −15,774−100.0% | Sold out |
| NinePointTwo Capital | 0 | $0 | 0.00% | −11,774−100.0% | Sold out |
| Lombard Odier Asset Management (USA) Corp | 0 | $0 | 0.00% | −11,177−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −8,048−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −4,760−100.0% | Sold out |
| Princeton Global Asset Management LLC | 0 | $0 | 0.00% | −2,500−100.0% | Sold out |
| Money Concepts Capital Corp | 0 | $0 | 0.00% | −2,150−100.0% | Sold out |
| U.S. Capital Wealth Advisors, LLC | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| Fairfield Financial Advisors, LTD | 0 | $0 | 0.00% | −80−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| SJS Investment Consulting Inc. | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −760−100.0% | Sold out |
| Rothschild & Co Asset Management US Inc. | – | – | – | – | Not filed |
| Burleson & Company, LLC | – | – | – | – | Not filed |